Bristol Myers Squibb nabs priority review tag for $3.15B arthritis drug Orencia to prevent transplant rejection
Bristol Myers Squibb nabs priority review tag for $3.15B arthritis [...]
Bristol Myers Squibb nabs priority review tag for $3.15B arthritis [...]
ESC: Amarin touts Vascepa’s ability to reduce repeat heart problems [...]
Pfizer, BioNTech score FDA’s first full COVID-19 vaccine nod, quickly [...]
Covis granted FDA hearing in latest twist over controversial premature-birth [...]
AstraZeneca’s Alexion buy takes first hit as Ultomiris fails in [...]
FibroGen scores a lifeline as Astellas-partnered roxadustat snags EU approval, [...]
Fierce Pharma Asia—China mRNA specialist’s $700M raise; Lilly-Innovent’s Tyvyt win; [...]
Moderna’s ‘Make it Yours’ vaccine campaign taps local partners like [...]
5 years after Pfizer buyout, SEC charges Medivation’s ex-dealmaking lead [...]
Advocates roll pricey ad campaigns as Biden, Congress push for [...]